MarketResearchNest.com adds “Global Sepsis Diagnostics Market 2017-2021” new reports to its research database. The report spread across 86 pages with tables and figures in it.
Analysts forecast the global sepsis diagnostics market to grow at a CAGR of 6.74% during the period 2017-2021.
Sepsis is a three-staged syndrome; it starts with systemic infections leading to severe sepsis and ultimately causing sepsis shock, which is regarded as a medical emergency. Population with weak immune system, which include children, older adults, and people with chronic diseases such as cancer, AIDS, diabetes, are prone to sepsis.
Sepsis occurs mainly due to bacterial, viral, and fungal infections. Gram-negative bacilli such as E. coli, P. aeruginosa, E. corrodens, and Haemophilus influenzae (which occurs mainly in neonates) are the main agents that cause infection, leading to sepsis. Other bacteria which causes sepsis are S. aureus, Streptococcus species, Enterococcus species, and Neisseria species.
Get more details about report at https://www.marketresearchnest.com/global-sepsis-diagnostics-market-2017-2021.html .
Covered in this report
The report covers the present scenario and the growth prospects of the global sepsis diagnostics market for 2017-2021. To calculate the market size, the report considers the sales, volume and value of global sepsis diagnostics segment.
The market is divided into the following segments based on geography:
• Americas
• APAC
• EMEA
Technavio’s report, Global Sepsis Diagnostics Market 2017-2021, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.
Key vendors
• bioMérieux
• T2 Biosystems
Other prominent vendors
• Alere
• Abionic
• AdvanDx
• Aethlon Medical
• AusDiagnostics
• Beckman Coulter
• Beckton Dickinson
• Momentum Bioscience
• Bio-Rad Laboratories
• Bruker
• Cepheid
• Curetis
• CytoSorbents
• Fast Track Diagnostics
• F. Hoffmann-La Roche
• Fujirebio Europe
• Hansa Medical
• Hain Lifescience
• Immunexpress
• Inflammatix
• Merck
• miacom diagnostics
• Mitsubishi Chemical Europe
• Nanōmix
• QIAGEN
• Radiometer
• Response Biomedical
• Sepset Biosciences
• Siemens Healthineers
• TCS Biosciences
• Thermo Fisher Scientific
Order a Purchase Report Copy at https://www.marketresearchnest.com/purchase.php?reportid=272808 .
Market driver
• Rising prevalence of hospital acquired infection (HAIs) globally
• For a full, detailed list, view our report
Market challenge
• High cost of sepsis treatment
• For a full, detailed list, view our report
Market trend
• Increasing use of biomarkers for sepsis
• For a full, detailed list, view our report
Key questions answered in this report
• What will the market size be in 2021 and what will the growth rate be?
• What are the key market trends?
• What is driving this market?
• What are the challenges to market growth?
• Who are the key vendors in this market space?
Inquire before buying this report at https://www.marketresearchnest.com/enquirybuy.php?reportid=272808 .
About Us:
MarketResearchNest.com is the most comprehensive collection of market research products and services on the Web. We offer reports from almost all top publishers and update our collection on daily basis to provide you with instant online access to the world’s most complete and recent database of expert insights on global industries, organizations, products, and trends.
Contact Us
Mr. Jeet Jain
Sales Manager
+1-240-284-8070 / +44-20-3290-4151
Your information will never be shared with any third party.